Multidisciplinary intensive outpatient rehabilitation program
Multidisciplinary intensive outpatient rehabilitation program has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Aug 20, 2026: “Effect of a multidisciplinary intensive outpatient rehabilitation program on plasma neurofilaments and myokines in Parkinson's disease: an exploratory analysis”.
1 paper studies it4 findingsUpdated
1 new paper in 30 daysSee all 1 papers on multidisciplinary intensive outpatient rehabilitation program
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“No significant changes over time or between groups were observed in motor or cognitive outcomes.”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Italian Ministry of University and Research and 1 more
- Human trial1
Studies in people
1 study gave multidisciplinary intensive outpatient rehabilitation program to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on motor and cognitive function up: Increases irisin down: Decreases NfL | Randomized trialpost-treatment and 3-month follow-up | 40 peopleParkinson's disease | Journal of neuroengineering and rehabilitation, Aug 20, 2026 |
What did studies of multidisciplinary intensive outpatient rehabilitation program find?
4Studies of multidisciplinary intensive outpatient rehabilitation program measured 4 outcomes, among them IL-6, NfL and irisin.
IL-6
no changein humans1
1 study
IL-6
no changein humans1
Multidisciplinary intensive outpatient rehabilitation program showed no clear effect on IL-6 in humans (Parkinson's disease; compared with a home-based self-managed intervention).
“IL-6 remained stable in both groups.”
Human trialParkinson's disease; compared with a home-based self-managed interventionplasmapost-treatment and 3-month follow-upn = 40
Journal of neuroengineering and rehabilitation
NfL
downin humans1
1 study
NfL
downin humans1
Multidisciplinary intensive outpatient rehabilitation program decreases NfL in humans (Parkinson's disease; compared with a home-based self-managed intervention).
“NFL levels significantly decreased in the EXP group at both time points, whereas an increase was observed at follow-up in the CTRL group.”
Human trialParkinson's disease; compared with a home-based self-managed interventionplasmapost-treatment and 3-month follow-upn = 40
Journal of neuroengineering and rehabilitation
Irisin
upin humans1
1 study
Irisin
upin humans1
Multidisciplinary intensive outpatient rehabilitation program increases irisin in humans (Parkinson's disease; compared with a home-based self-managed intervention).
“Irisin levels increased in the EXP group at T1 and T2, while decreasing in the CTRL group (p < 0.01).”
Human trialParkinson's disease; compared with a home-based self-managed interventionplasmapost-treatment and 3-month follow-upn = 40
Journal of neuroengineering and rehabilitation
Motor and cognitive function
no changein humans1
1 study
Motor and cognitive function
no changein humans1
Multidisciplinary intensive outpatient rehabilitation program showed no clear effect on motor and cognitive function in humans (Parkinson's disease; compared with a home-based self-managed intervention).
“No significant changes over time or between groups were observed in motor or cognitive outcomes.”
Human trialParkinson's disease; compared with a home-based self-managed interventionpost-treatment and 3-month follow-upn = 40
Journal of neuroengineering and rehabilitation